心臟去颤器的全球市场 - 市场规模，占有率，成长分析:各类型，各最终用途 - 产业预测(2023年～2030年)

Global Cardioverter Defibrillator Device Market Size, Share, Growth Analysis, By Type(implantable cardioverter defibrillators, external cardioverter defibrillators), By End use(hospitals, pre-hospital) - Industry Forecast 2023-2030

出版日期: 2023年07月12日 | 出版商:

SkyQuest | 英文 224 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球心臟去颤器的市场规模将从2021年的111亿9,000万美元到2030年达到208亿美元，在预测期间(2023年～2030年)时将以年复合成长率7.2％的速度成长。

市场，表示着被全球心血管疾病的流行牵引，稳定了的成长。技术的进步和早期诊断·治疗选择的认识的提高，更加在全球心血管疾病患病率上升的推动下，全球心臟復律除颤设备市场正在稳步增长。这些设备通过检测不规则的心律并提供电击以恢復正常心跳，在预防心臟骤停方面发挥着至关重要的作用。技术进步和人们对早期诊断和治疗选择的认识不断提高，进一步推动了市场的扩张。对植入式心律转復除颤器（ICD）和体外除颤器的需求不断增长，表明全球心律转復除颤器设备市场前景光明。

促进因素

除颤器在降低成本、减小尺寸和易用性方面取得了显着进步。技术进步包括自动体外除颤器（AED）和植入式心律转復除颤器（ICD）的开发。这些设备在管理心脏病方面非常有效。随着除颤器技术的进步，对于经过培训的人员来说，操作该设备变得更加简单。

阻碍因素

心臟復律除颤器的成本构成了重大障碍，特别是对于低收入背景的患者。此外，有限的医疗保健预算可能会促使未来这些设备的采用率较低。

趋势

智慧起搏器是一种创新设备，能够检测心臟功能最轻微的异常情况。它可以解决心臟异常并恢復正常的身体功能。此外，它还向患者和医生提供有关患者心臟健康状况的警报。智慧起搏器的这一功能有助于降低死亡率。

本报告提供全球心臟去颤器市场相关调查分析，提供市场动态及预测，市场区隔分析，企业简介等资讯。

Medtronic plc
Abbott Laboratories
Boston Scientific Corporation
Biotronik SE & Co. KG
Koninklijke Philips N.V.
LivaNova PLC
Microport Scientific Corporation
Nihon Kohden Corporation
Progetti Srl
Schiller AG
Zoll Medical Corporation (a subsidiary of Asahi Kasei Corporation)
Stryker Corporation
Defibtech, LLC
Cardiac Science Corporation
Physio-Control International (a subsidiary of Stryker Corporation)
CU Medical Systems, Inc.
Fukuda Denshi Co., Ltd.
Mindray Medical International Limited
Welch Allyn, Inc. (a subsidiary of Hill-Rom Holdings, Inc. )
Cardionet (a subsidiary of BioTelemetry, Inc. )

简介目录

Product Code: SQMIG35A2207

Global Cardioverter Defibrillator Device market size was valued at USD 11.19 billion in 2021 and is poised to grow to USD 20.8 billion by 2030, growing at a CAGR of 7.2% in the forecast period (2023-2030).

The global market for cardioverter defibrillator devices is witnessing steady growth, driven by the rising prevalence of cardiovascular diseases worldwide. These devices play a crucial role in the prevention of sudden cardiac arrests by detecting irregular heart rhythms and delivering electric shocks to restore normal heartbeats. Technological advancements and increasing awareness about early diagnosis and treatment options are further fueling market expansion. The growing demand for implantable cardioverter defibrillators (ICDs) and external defibrillators indicate a promising future for the global cardioverter defibrillator device market.

Top-down and bottom-up approaches were used to estimate and validate the size of Cardioverter Defibrillator Device and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report:

Cardioverter Defibrillator Device market is segmented based on the Products, Technology, End User and region. Based on the Products, the Cardioverter Defibrillator Device market is segmented into software and services. Based on the technology, the Cardioverter Defibrillator Device Market has been segmented into Web based software, Cloud based software. Based on end users Cardioverter Defibrillator Device Market is segmented into Hospitals, Clinics, Ambulatory Surgery Centre, Diagnostic Centres and Others. Based on Region Cardioverter Defibrillator Device Market is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Driver

Defibrillators have made significant advancements in terms of cost reduction, size reduction, and ease of use. The technological progress includes the development of automated external defibrillators (AEDs) and implantable cardioverter defibrillators (ICDs). These devices are highly effective in managing cardiac conditions. With the advancements in defibrillator technology, operating the device has become simpler for trained individuals.

Restrain

The cost of cardioverter defibrillators poses a significant barrier, particularly for patients from low-income backgrounds. Additionally, limited healthcare budgets may result in a lower adoption rate of these devices in the future.

Trend

A smart pacemaker is an innovative device capable of detecting even the slightest irregularities in heart function. It addresses abnormalities in the heart and restores normal bodily functions. Furthermore, it provides alerts to both patients and physicians regarding the patient's cardiac health. This feature of the smart pacemaker contributes to reducing mortality rates.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
- Regulatory Landscape
- Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global Cardioverter Defibrillator Device Market by Type
- Market Overview
- implantable cardioverter defibrillators
- external cardioverter defibrillators
Global Cardioverter Defibrillator Device Market by End use
- Market Overview
- hospitals
- pre-hospital
- public access market
- alternative care
- home
Global Cardioverter Defibrillator Device Market Size by Region
- Market Overview
- North America
USA
Canada
- Europe
Germany
Spain
France
UK
Rest of Europe
- Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
- Latin America
Brazil
Rest of Latin America
- Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
By Development
By Company
By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Medtronic plc
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Abbott Laboratories
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Boston Scientific Corporation
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Biotronik SE & Co. KG
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Koninklijke Philips N.V.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- LivaNova PLC
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Microport Scientific Corporation
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Nihon Kohden Corporation
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Progetti Srl
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Schiller AG
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Zoll Medical Corporation (a subsidiary of Asahi Kasei Corporation)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Stryker Corporation
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Defibtech, LLC
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Cardiac Science Corporation
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Physio-Control International (a subsidiary of Stryker Corporation)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- CU Medical Systems, Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Fukuda Denshi Co., Ltd.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Mindray Medical International Limited
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Welch Allyn, Inc. (a subsidiary of Hill-Rom Holdings, Inc.)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Cardionet (a subsidiary of BioTelemetry, Inc.)
Company Overview
Business Segment Overview
Financial Updates
Key Developments